HOME
SEARCH
RSS FEED
SUBSCRIBE
Novel Small-Molecule Antidepressants
Case ID:
01.067
Web Published:
4/1/2014
These potential antidepressant compounds have a novel mechanism of action – blockade of transporters for the neurotransmitters norepinephrine, serotonin, and dopamine. This novel “triple reuptake blockade” approach holds promise for a more effective and rapidly-acting antidepressant.
Patent Information:
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Patent Status
Category(s):
Medical
Biotechnology
Bookmark this page
Download as PDF
For Information, Contact:
Rob Whitehead
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9219
rwhitehead@vtip.org
Inventors:
Paul Carlier
Elliott Richelson
Keywords:
Pharmaceuticals & Biotechnology